OUR TEAM

Mauro Mileni, PhD

Founder & Chief Executive Officer

Joel Edwards, MBA

Chief Business Officer

Jim Schmidt

Chief Financial Officer

Christopher B. Roth, PhD

Vice President, Research

Layton Harris Smith, Ph.D.

Vice President, Preclinical Development

Karen Chiang, PhD

Senior Research Scientist

Roberto Jappelli, PhD

Principal Scientist

Sunghoon Kim, PhD

Senior Research Scientist

Le Li, PhD

Senior Research Scientist

Prasenjit Saha

Research Scientist

Kin Moy, BSc

Lab Manager/Research Associate

Mark Gustinic

Senior Research Associate

Jeffrey Cho

Research Associate

Nael Mohammed Mousa

Senior Research Associate

DIRECTORS OF THE BOARD

Daniel Bradbury

Director of the Board

Michael Goguen

Director of the Board

Mauro Mileni

Founder & CEO

SCIENTIFIC ADVISORS

Tom Boone

Antibody Discovery Advisor

Prof. Tracy Handel, PhD

Pharmacology Advisor

Anke Kretz-Rommel, PhD

Antibody Development Advisor

Fred Ramsdell, PhD

Oncology Advisor

EXECUTIVE ADVISORS

Don Rindell

Managing Director of Camino International

Charlie Rodi, PhD

Founder and CEO of RhoDx, Inc.

R. Scott Struthers, PhD

CEO of Crinetics Pharmaceuticals